﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Wed, 06 May 2026 13:07:45 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/January-2022/rss/3133</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/January-2022/rss/3133" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New and Approved]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-44</link><description><![CDATA[  APhA Staff  

   New drug   

 MARIBAVIR 
(Livtencity—Takeda Pharmaceuticals USA, Inc.) 

  Drug class:  Cytomegalovirus (CMV) pUL97 kinase inhibitor. 

  Indication:  Livtencity is ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-44</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3100]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[ACIP issues recommendations for zoster, pneumococcal vaccines]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/acip-issues-recommendations-for-zoster-pneumococcal-vaccines</link><description><![CDATA[  Maria G. Tanzi, PharmD  

 At a recent meeting of CDC’s Advisory Committee of Immunization Practices (ACIP), the group recommended recombinant zoster vaccine (RZV) for adults 19 years and older ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/acip-issues-recommendations-for-zoster-pneumococcal-vaccines</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3093]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Study links statins with more aggressive diabetes progression]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/study-links-statins-with-more-aggressive-diabetes-progression-1</link><description><![CDATA[  Loren Bonner  

 Patients with diabetes who used statins experienced less control of their diabetes than patients who did not take statins, suggests a new retrospective study published in  JAMA ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/study-links-statins-with-more-aggressive-diabetes-progression-1</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3094]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Do ditans and gepants have a place in acute migraine treatment?]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/do-ditans-and-gepants-have-a-place-in-acute-migraine-treatment</link><description><![CDATA[  Clarissa Chan, PharmD  

   

 A systematic review and meta-analysis by Yang and colleagues, published in  JAMA Open Network  in October 2021, found that 5-HT1F receptor agonists or “ditans” ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/do-ditans-and-gepants-have-a-place-in-acute-migraine-treatment</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3095]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Polypharmacy, certain medication classes seem to worsen COVID-19 outcomes]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/polypharmacy-certain-medication-classes-seem-to-worsen-covid-19-outcomes-1</link><description><![CDATA[  Loren Bonner  

 Pharmacists are well aware that polypharmacy is a major issue among patients, especially older adults. Recent studies have estimated that approximately 36% of older adults take ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/polypharmacy-certain-medication-classes-seem-to-worsen-covid-19-outcomes-1</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3096]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[FDA approves new prescription medication for dry eye disease]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/fda-approves-new-prescription-medication-for-dry-eye-disease</link><description><![CDATA[  Johanna Taylor Katroscik, PharmD  

   

 In October 2021, FDA announced the approval of Tyrvaya, a first-in-class medication to treat the signs and symptoms of dry eye disease. Tyrvaya is a ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/fda-approves-new-prescription-medication-for-dry-eye-disease</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3097]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Brain-boosting supplements… do they work?]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/brain-boosting-supplements-do-they-work</link><description><![CDATA[  Johanna Taylor Katroscik, PharmD  

   

 According to a 2019 Brain Health and Dietary Supplements Survey conducted by AARP, over 25% of Americans age 50 and up use some sort of supplement to ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/brain-boosting-supplements-do-they-work</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3098]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Insomnia]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/insomnia</link><description><![CDATA[  Daniel L. Krinsky, BS, MS, RPh, FAPhA  

   

 Welcome to 2022! As we continue to navigate stressful and uncertain times, an issue such as insomnia—normally a fairly common complaint— will ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/insomnia</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3099]]></dc:identifier></item></channel></rss>